Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Laurin Wagner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|August 11, 2022
The uncut version: base-edited allo-CAR T cellsDimitrios Laurin Wagner
Blood|June 1, 2023
Splendid isolationDimitrios Laurin Wagner, Maksim Mamonkin
Molecular Therapy. Methods & Clinical Development|November 29, 2023
New dawn of cellular therapies in autoimmune diseasesDimitrios Laurin Wagner, Lennard Ostendorf
Gene Therapy|February 12, 2021
Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?Dimitrios Laurin Wagner, Lena Peter, Michael Schmueck-Henneresse
Kidney International|April 23, 2025
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitisUwe Jerke, Claudia Eulenberg-Gustavus, Dimitrios Laurin Wagner, et al.
RMD Open|January 10, 2023
Daratumumab for the treatment of refractory ANCA-associated vasculitisLennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2020
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant RecipientsLeila Amini, Dimitrios Laurin Wagner, Uta Rössler, et al.
Biofabrication|July 2, 2024
Long-term<i>in vitro</i>maintenance of plasma cells in a hydrogel-enclosed human bone marrow microphysiological 3D model systemStefania Martini, Norman Michael Drzeniek, Regina Stark, et al.
Molecular Therapy. Methods & Clinical Development|March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patientsLena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Molecular Therapy. Nucleic Acids|March 16, 2026
mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cellsNourhan Kahwaji, Niklas Kotzian, Jasmin Melissa Prinz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|August 11, 2022
The uncut version: base-edited allo-CAR T cellsDimitrios Laurin Wagner
Blood|June 1, 2023
Splendid isolationDimitrios Laurin Wagner, Maksim Mamonkin
Molecular Therapy. Methods & Clinical Development|November 29, 2023
New dawn of cellular therapies in autoimmune diseasesDimitrios Laurin Wagner, Lennard Ostendorf
Gene Therapy|February 12, 2021
Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?Dimitrios Laurin Wagner, Lena Peter, Michael Schmueck-Henneresse
Kidney International|April 23, 2025
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitisUwe Jerke, Claudia Eulenberg-Gustavus, Dimitrios Laurin Wagner, et al.
RMD Open|January 10, 2023
Daratumumab for the treatment of refractory ANCA-associated vasculitisLennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2020
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant RecipientsLeila Amini, Dimitrios Laurin Wagner, Uta Rössler, et al.
Biofabrication|July 2, 2024
Long-term<i>in vitro</i>maintenance of plasma cells in a hydrogel-enclosed human bone marrow microphysiological 3D model systemStefania Martini, Norman Michael Drzeniek, Regina Stark, et al.
Molecular Therapy. Methods & Clinical Development|March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patientsLena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Molecular Therapy. Nucleic Acids|March 16, 2026
mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cellsNourhan Kahwaji, Niklas Kotzian, Jasmin Melissa Prinz, et al.
Pageof 2